HVQY75- Evaluate the results of the first 6 kidney transplants performed at Laos Central Military Hospital 103

Keovithoun Vibounmy1, , Dalasat Savengxay , Khinthavong Khonevilay, Philavong Pan , Phommavongsa Phimmasone, Inthavong Vongmyxay, Lorsingkham Sonephay, Nhất Định Vũ, Văn Nam Nguyễn, Inthavong Buasing
1 Bệnh viện Trung ương Quân đội 103 Lào

Main Article Content

Abstract

Objective: Evaluate the results of the first 6 kidney transplants performed at Laos Central Military Hospital 103. Research methods: Descriptive study, prospective longitudinal follow-up from October 2022 - October 2023 in 6 end-stage CKD patients receiving kidney transplants from living donors. Results: At 6 months after transplantation, no post-transplant complications were recorded. Kidney function gradually stabilized in the first 6 months after transplantation as shown by urea index, blood creatinine and estimated glomerular filtration rate; Tacrolimus concentration C0 gradually stabilized to the recommended threshold; Post-transplantation improves hypertension and anemia; Hematological indices including: white blood cells and hemoglobin gradually stabilized to normal levels, no changes in platelet index were recorded. Conclusion: After 6 months of transplantation, all 6 patients had no complications that needed to be treated. Kidney function gradually stabilized and disorders before and in the early stages after transplantation improved.

Article Details

References

1. Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 2017; 390(10100):1151-1210.
2. Augustine J. Kidney transplant: New opportunities and challenges. CCJM. 2018; 85(2):138-144.
3. Eckardt KU, Kasiske BL, and Zeier MG. Special Issue: KDIGO clinical practice guideline for the care of kidney transplant recipients. American Journal of Transplantation. 2009; 9:s1-s155.
4. Everly MJ, Rebellato LM, Haisch CE, et al. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation. 2013; 95(3):410-417.
5. Hội ghép tạng Việt Nam. 2017.
6. Alagoz S, Seyahi N. Frequency of human leukocyte antigens and donor specific antibodies in long-term living donor kidney transplantation. Transplantation Proceedings. 2019; 51(7):2302-2307.
7. EAU 2023. Guidelines on renal transplantation. 2023.
8. BC 2021. Clinical guidelines for kidney transplantation.